Lipid composition heatmap for Study ST003629

Select 2 experimental conditions (at least one from A and at least one from B) to compare lipid profiles.
Group ACombined factors (this analysis)Group B
Variant/Subject:PSMC5 AM (Pittsburgh) | alteration in PSMC5 protein:R201W | comment:Patient
Variant/Subject:PSMC5 BC (Pittsburgh) | alteration in PSMC5 protein:None | comment:Control/mother of AM
Variant/Subject:PSMC5 BLG (Montpellier) | alteration in PSMC5 protein:R325W | comment:Patient
Variant/Subject:PSMC5 BN (Angers) | alteration in PSMC5 protein:E205V | comment:Patient
Variant/Subject:PSMC5 Bro (Prague) | alteration in PSMC5 protein:None | comment:Control/Brother of DelExon4
Variant/Subject:PSMC5 Bro (Prague) | alteration in PSMC5 protein:None | comment:Control/Brother of DelExon5
Variant/Subject:PSMC5 Bro (Prague) | alteration in PSMC5 protein:None | comment:Control/Brother of DelExon6
Variant/Subject:PSMC5 Bro (Prague) | alteration in PSMC5 protein:None | comment:Control/Brother of DelExon7
Variant/Subject:PSMC5 DelExon4 (Prague) | alteration in PSMC5 protein:Delta Exon 4 | comment:Patient
Variant/Subject:PSMC5 FN (Angers) | alteration in PSMC5 protein:None | comment:Control/father of BN
Variant/Subject:PSMC5 JFL (Nantes) | alteration in PSMC5 protein:PSMD11 R90* | comment:Control/father of LL
Variant/Subject:PSMC5 JLG (Montpellier) | alteration in PSMC5 protein:None | comment:Control/father of BLG
Variant/Subject:PSMC5 JS (New-York) | alteration in PSMC5 protein:P320R | comment:Patient
Variant/Subject:PSMC5 LL (Nantes) | alteration in PSMC5 protein:PSMD11R90*/Q221R | comment:Patient
Use log scale for A and B heatmaps(enhance less abundant metabolites):
Select a lipid RefMet sub class:    

Lipid sub classes in this studyNumber in study
Acyl carnitines16
BMP13
Cer68
Chol. esters24
DAG94
DHCer15
Hex2Cer10
HexCer54
LPC36
LPE28
LPG1
LPI2
LPS1
O-LPC6
O-LPE1
O-PC156
O-PE191
O-PI2
O-PS2
PA3
PC260
PE163
PG39
PI57
PS74
SM12
TAG653
  logo